Supply Chain

Community Health Ventures recently entered into a group purchasing agreement with Mundelein, Ill.-based Medline under its Value in Purchasing Program.

Here are the five latest medical devices or drugs approved by the Food and Drug Administration.

With the supply chain representing the second biggest expense on hospitals' balance sheets1, the need to eliminate waste and gain efficiencies is constant. However, most organizations' current supply chain infrastructure fails to support waste-reducing efforts and poses a significant drain on…

The Food and Drug Administration recently approved Sun Pharmaceuticals' metformin hydrochloride tablets to improve glycemic control in adults with Type 2 diabetes.

Boston Scientific earned approval from the Food and Drug Administration for its Emblem MRI Subcutaneous Implantable Defibrillator.

The Food and Drug Administration awarded priority review status for a drug intended to treat a childhood-onset form of muscular dystrophy, according to the Chicago Tribune.

The Food and Drug Administration is working to make naloxone more available, stated Karen Mahoney, MD, deputy director for the division of nonprescription drug products at the Center for Drug Evaluation and Research, in a post on the agency's website.

The online market for the sale of illegal drugs has dramatically increased in the last three years, according to a recent study by RAND Europe.

The Texas Medical Center Innovation Institute in Houston welcomed 11 medical device startups to its accelerator program TMCx this week.

AstraZeneca invested an additional $140 million in Moderna Therapeutics, a Cambridge, Mass.-based biotech developing drug treatments using messenger RNA, reported Reuters.